Paper35582425
The Emerging Portrait of Glial Cell Line-derived Neurotrophic Factor Family Receptor Alpha (GFRα) in Cancers.
Li Q and 2 others. Int J Med Sci, 2022. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. The Emerging Portrait of Glial Cell Line-derived Neurotrophic Factor Family Receptor Alpha (GFRα) in Cancers. Papers, record 35582425. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35582425
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Emerging Portrait of Glial Cell Line-derived Neurotrophic Factor Family Receptor Alpha (GFRα) in Cancers.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drosophila Proteins | Major topic |
| Neoplasms | Major topic |
| Glial Cell Line-Derived Neurotrophic Factor | |
| Glial Cell Line-Derived Neurotrophic Factor Receptors | |
| Humans | |
| Proto-Oncogene Proteins | |
| Proto-Oncogene Proteins c-ret |
Source PubMed
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24067900 | The neurotrophic factor neurturin contributes toward an aggressive cancer cell phenotype, neuropathic pain and neuronal plasticity in pancreatic cancer. | Carcinogenesis | 2014 | https://conductscience.org/library/papers/24067900 | PubMed |
| 2 | 24737320 | Artemin, a member of the glial cell line-derived neurotrophic factor family of ligands, is HER2-regulated and mediates acquired trastuzumab resistance by promoting cancer stem cell-like behavior in mammary carcinoma cells. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24737320 | PubMed |
| 3 | 30755808 | Perineural invasion of cancer: a complex crosstalk between cells and molecules in the perineural niche. | Am J Cancer Res | 2019 | https://conductscience.org/library/papers/30755808 | PubMed |
| 4 | 11861385 | The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes. | Cancer Res | 2002 | https://conductscience.org/library/papers/11861385 | PubMed |
| 5 | 18597864 | GDNF and GFRalpha: a versatile molecular complex for developing neurons. | Trends Neurosci | 2008 | https://conductscience.org/library/papers/18597864 | PubMed |
| 6 | 27754745 | GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy. | Autophagy | 2017 | https://conductscience.org/library/papers/27754745 | PubMed |
| 7 | 17310246 | GDNF and GFRalpha1 promote formation of neuronal synapses by ligand-induced cell adhesion. | Nat Neurosci | 2007 | https://conductscience.org/library/papers/17310246 | PubMed |
| 8 | 20210798 | Analysis of DOK-6 function in downstream signaling of RET in human neuroblastoma cells. | Cancer Sci | 2010 | https://conductscience.org/library/papers/20210798 | PubMed |
| 9 | 19741142 | Role of glial cell line-derived neurotrophic factor (GDNF)-neural cell adhesion molecule (NCAM) interactions in induction of neurite outgrowth and identification of a binding site for NCAM in the heel region of GDNF. | J Neurosci | 2009 | https://conductscience.org/library/papers/19741142 | PubMed |
| 10 | 15982921 | RET tyrosine kinase signaling in development and cancer. | Cytokine Growth Factor Rev | 2005 | https://conductscience.org/library/papers/15982921 | PubMed |
| 11 | 28490466 | RET Signaling in Prostate Cancer. | Clin Cancer Res | 2017 | https://conductscience.org/library/papers/28490466 | PubMed |
| 12 | 22901124 | Neurotrophic artemin promotes motility and invasiveness of MIA PaCa-2 pancreatic cancer cells. | Asian Pac J Cancer Prev | 2012 | https://conductscience.org/library/papers/22901124 | PubMed |
| 13 | 32737575 | RET-independent signaling by GDNF ligands and GFRα receptors. | Cell Tissue Res | 2020 | https://conductscience.org/library/papers/32737575 | PubMed |
| 14 | 20960036 | High glucose promotes cell proliferation and enhances GDNF and RET expression in pancreatic cancer cells. | Mol Cell Biochem | 2011 | https://conductscience.org/library/papers/20960036 | PubMed |
| 15 | 16820412 | Dok-4 regulates GDNF-dependent neurite outgrowth through downstream activation of Rap1 and mitogen-activated protein kinase. | J Cell Sci | 2006 | https://conductscience.org/library/papers/16820412 | PubMed |
| 16 | 24526731 | Inhibition of RET increases the efficacy of antiestrogen and is a novel treatment strategy for luminal breast cancer. | Clin Cancer Res | 2014 | https://conductscience.org/library/papers/24526731 | PubMed |
| 17 | 26984265 | GFRA3 promoter methylation may be associated with decreased postoperative survival in gastric cancer. | BMC Cancer | 2016 | https://conductscience.org/library/papers/26984265 | PubMed |
| 18 | 25243385 | Neurotrophic Factor Artemin Promotes Invasiveness and Neurotrophic Function of Pancreatic Adenocarcinoma In Vivo and In Vitro. | Pancreas | 2015 | https://conductscience.org/library/papers/25243385 | PubMed |
| 19 | 23085183 | Structural studies of GDNF family ligands with their receptors-Insights into ligand recognition and activation of receptor tyrosine kinase RET. | Biochim Biophys Acta | 2013 | https://conductscience.org/library/papers/23085183 | PubMed |
| 20 | 9491986 | Persephin, a novel neurotrophic factor related to GDNF and neurturin. | Neuron | 1998 | https://conductscience.org/library/papers/9491986 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41176212 | Enhanced prediction of breast cancer patient response to chemotherapy by integrating deconvolved expression patterns of immune, stromal and tumor cells. | Cancer Lett | 2026 | https://conductscience.org/library/papers/41176212 | PubMed |
| 41142827 | Neurotrophic factors as double-edged swords in osteosarcoma: drivers of tumour growth and immune remodelling. | Front Immunol | 2025 | https://conductscience.org/library/papers/41142827 | PubMed |
| 40686838 | Single-Cell Transcriptome Analyses of Four Pain Related Genes in Osteosarcoma. | Cancer Inform | 2025 | https://conductscience.org/library/papers/40686838 | PubMed |
| 39372749 | Enhanced prediction of breast cancer patient response to chemotherapy by integrating deconvolved expression patterns of immune, stromal and tumor cells. | bioRxiv | 2025 | https://conductscience.org/library/papers/39372749 | PubMed |
| 39175618 | Assessment of CRISPRa-mediated gdnf overexpression in an In vitro Parkinson's disease model. | Front Bioeng Biotechnol | 2024 | https://conductscience.org/library/papers/39175618 | PubMed |
| 37566075 | Unveiling the Neural Environment in Cancer: Exploring the Role of Neural Circuit Players and Potential Therapeutic Strategies. | Cells | 2023 | https://conductscience.org/library/papers/37566075 | PubMed |
Genes47
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35582425
GET https://conductscience.org/api/papers/v1/35582425/references?page=2